Atlas Trials

A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants

Clinical trial NCT02985632 · WITHDRAWN

Trial details

NCT number
NCT02985632
Sponsor
Bristol-Myers Squibb
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2017-01-11
Primary completion
2017-05-18
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.